16 Yamada H. Anti-viral compositions containing new glycoprotein from Isatis tintoria. Japanese Patent, 1160599, 1999 Mar 02.
[8]
17 Hayashi K, Kamiya M, Hayashi T. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV. Planta Med, 1995, 61: 237-241
[9]
18 Choi H J, Song J H, Park K S, et al. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur J Pharm Sci, 2009, 37: 329-333
20 Ge H, Wang Y F, Xu J, et al. Anti-influenza agents from traditional Chinese medicine. Nat Prod Rep, 2010, 27: 1758-1780
[12]
21 Chen J X, Xue H J, Ye W C, et al. Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro. Biol Pharm Bull, 2009, 32: 1385-1391
23 Nagai T, Moriguchi, R, Suzuki Y, et al. Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4''-trihydroxy- 8-methoxyflavone, from the roots of Scutellaria baicalensis. Antiviral Res, 1995, 26: 11-25
28 Kobayashi M, Davis S M, Utsunomiya T, et al. Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in mice. Am J Chin Med, 1999, 27: 53-62
31 Mantani N, Andoh T, Kawamata H, et al. Inhibitory effect of Ephedrae herba, an oriental traditional medicine, on the growth of influenza A/PR/8 virus in MDCK cells. Antiviral Res, 1999, 44: 193-200
[23]
32 Yu C H, Yan Y L, Wu X N, et al. Anti-influenza virus effects of the aqueous extract from Mosla scabra. J Ethnopharmacol, 2010, 127: 280-285
[24]
33 Shimizu T, Hino A, Tsutsumi A, et al. Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice. Antivir Chem Chemoth, 2008, 19: 7-13
38 Jeong H J, Ryu Y B, Park S J, et al. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorgan Med Chem, 2009, 17: 6816-6823
[30]
39 Lee C L, Chiang L C, Cheng L H, et al. Influenza A (H1N1) antiviral and cytotoxic agents from Ferula assa-foetida. J Nat Prod, 2009, 72: 1568-1572
[31]
40 Chon H. Medicinal herbs and plant extracts for influenza: bioactivity, mechanism of anti-influenza effects, and modulation of immune responses. Stud Nat Prod Chem, 2012, 38: 305-323
[32]
41 Nakayama M, Suzuki K, Toda M, et al. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res, 1993, 21: 289-299
70 Liu S W, Jiang S B. High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques. Curr Pharm Des, 2004, 10: 1827-1843
[39]
71 Choi J H, Croyle M A. Emerging targets and novel approaches to Ebola virus prophylaxis and treatment. BioDrugs, 2013, 27: 565-583
[40]
72 Cote M, Misasi J, Ren T, et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature, 2011, 477: 344-348
[41]
73 Warren T K, Warfield K L, Wells J, et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med, 2010, 16: 991-994
1 Gao G F, Feng Y. On the ground in Sierra Leone. Science, 2014, 346: 666
[44]
2 Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 2014, 514: 47-53
[45]
3 Geisbert T W, Lee A C, Robbins M, et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet, 2010, 375: 1896-1905
[46]
4 Warren T K, Wells J, Panchal R G, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature, 2014, 508: 402-405
47 Liu A L, Liu B, Qin H L, et al. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med, 2008, 74: 847-851
55 Tang J, Colacino J M, Larsen S H, et al. Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. Antivir Res, 1990, 13: 313-325
65 Yang J, Li M M, Shen X T, et al. Influenza A virus entry inhibitors targeting the hemagglutinin. Viruses, 2013, 5: 352-373
[71]
66 Hunt C L, Lennemann N J, Maury W. Filovirus entry: a novelty in the viral fusion world. Viruses, 2012, 4: 258-275
[72]
67 Olinger G G Jr, Pettitt J, Kim D, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci USA, 2012, 109: 18030-18035
[73]
68 Basu A, Li B, Mills D M, et al. Identification of a small-molecule entry inhibitor for filoviruses. J Virol, 2011, 85: 3106-3119
[74]
69 Liu S W, Li R M, Zhang R T, et al. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. Eur J Pharmacol, 2011, 660: 460-467
